Capra Biosciences is developing a new technology that will make the manufacturing of chemicals using biology cost-competitive with petroleum-based products. Significant advances in synthetic biology have been made over the past 20 years, enabling a multitude of products with lower environmental impact and potentially better performance than their petrochemical counterparts. However, cost-competitive large-scale manufacturing of these products remains a significant bottleneck to their adaptation. Our technology tackles this bottleneck through an innovative bioreactor design that promises to significantly reduce end-to-end manufacturing costs.
Company Details
- Employees
- 19
- Address
- Manassas, Va 20109, Us
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- http://www.caprabiosciences.com
- HQ
- MANASSAS, VA
Capra Biosciences Questions
Capra Biosciences's website is http://www.caprabiosciences.com
Capra Biosciences's LinkedIn profile is https://www.linkedin.com/company/capra-biosciences
Capra Biosciences has
19 employees.
View email and phone details for 19
employees at Capra Biosciences.
Capra Biosciences's industry is
Biotechnology Research
Capra Biosciences's top competitors are
Tandem Repeat,
Lignolix,
Atcc,
Bonumose,
Biomade,
Drive Catalyst,
Next Rung Technology,
Athari Biosciences,
Virginia Bio,
Mango Materials.
Capra Biosciences's categories are Biotechnology Research
